Suits LA's Harvey Specter return could mean that the spinoff will solve a big mystery Suits didn't have the time to address ...

BMO Capital analyst Kostas Biliouris downgraded the rating on 4D Molecular Therapeutics (FDMT – Research Report) to a Hold today, setting a price target of $15.00. Discover outperforming stocks ...